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Area asymmetry of heart rate variability 
signal
Chang Yan1, Peng Li1, Lizhen Ji1, Lianke Yao1, Chandan Karmakar2 and Changchun Liu1*
Background
Heart rate variability (HRV), commonly indicated by the variation within the time inter-
val between heartbeats, has been intensively studied for several decades [1, 2]. It comes 
from the spontaneity of the sinoatrial (SA) node as well as the adaptability or resilience of 
SA node to the stimuli of both internal control system (e.g., autonomic nervous system) 
Abstract 
Background: Heart rate fluctuates beat-by-beat asymmetrically which is known as 
heart rate asymmetry (HRA). It is challenging to assess HRA robustly based on short-
term heartbeat interval series.
Method: An area index (AI) was developed that combines the distance and phase 
angle information of points in the Poincaré plot. To test its performance, the AI was 
used to classify subjects with: (i) arrhythmia, and (ii) congestive heart failure, from the 
corresponding healthy controls. For comparison, the existing Porta’s index (PI), Guzik’s 
index (GI), and slope index (SI) were calculated. To test the effect of data length, we 
performed the analyses separately using long-term heartbeat interval series (derived 
from >3.6-h ECG) and short-term segments (with length of 500 intervals). A second 
short-term analysis was further carried out on series extracted from 5-min ECG.
Results: For long-term data, SI showed acceptable performance for both tasks, i.e., 
for task i p < 0.001, Cohen’s d = 0.93, AUC (area under the receiver-operating charac-
teristic curve) = 0.86; for task ii p < 0.001, d = 0.88, AUC = 0.75. AI performed well for 
task ii (p < 0.001, d = 1.0, AUC = 0.78); for task i, though the difference was statistically 
significant (p < 0.001, AUC = 0.76), the effect size was small (d = 0.11). PI and GI failed 
in both tasks (p > 0.05, d < 0.4, AUC < 0.7 for all). However, for short-term segments, 
AI indicated better distinguishability for both tasks, i.e., for task i, p < 0.001, d = 0.71, 
AUC = 0.71; for task ii, p < 0.001, d = 0.93, AUC = 0.74. The rest three measures all failed 
with small effect sizes and AUC values (d < 0.5, AUC < 0.7 for all) although the differ-
ence in SI for task i was statistically significant (p < 0.001). Besides, AI displayed smaller 
variations across different short-term segments, indicating more robust performance. 
Results from the second short-term analysis were in keeping with those findings.
Conclusion: The proposed AI indicated better performance especially for short-term 
heartbeat interval data, suggesting potential in the ambulatory application of cardio-
vascular monitoring.
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and external ever-changing environment [3, 4]. In other words, HRV may help under-
stand how well the underlying control mechanism works and further, provides an oppor-
tunity to capture the tiny but early signs that may predict the future cardiovascular risk in 
healthy individuals, for whom invasive and costly assessments are usually infeasible.
Various methods have been established for assessing HRV [5, 6]. However, increasing 
efforts are most recently made to develop those that can understand the dynamics of 
heart rate (HR) [7, 8], e.g., Poincaré plot which is able to not only visualize but also quan-
titatively evaluate the oscillatory patterns of HRV [6, 9–18]. The Poincaré plot draws 
the current RR interval against the preceding one [15, 19], resulting in a scatter diagram 
which visualizes both the increase and decrease of HR. It thus may imply important 
information about the balance between sympathetic and parasympathetic activities. Pre-
vious studies have indicated that the Poincaré plot is physiologically asymmetric with 
respect to line of identity (the line on which the current heartbeat interval is identical 
to the preceding one) [14, 15] and this asymmetry changes in diseases, e.g., arrhythmia 
[19], heart failure [16], obstructive sleep apnea [20], myocardial infarction [21, 22], post-
operative myocardial ischemia [23], and type 1 diabetes [24], etc., suggesting possibly an 
imbalance in autonomic control under those pathological conditions.
Several measures have been developed to assess the asymmetry of Poincaré plot (or 
termed as heart rate asymmetry, HRA), e.g., Porta’s index (PI) evaluates the asymmetry 
of the amounts of points located in two regions of Poincaré plot separated by the line 
of identity [11], Guzik’s index (GI) measures the asymmetry based on the cumulative 
distance of each point to the line of identity [9], and slope index (SI) quantifies the asym-
metry of the phase angles [19]. In this study, we proposed that the asymmetry could 
also be assessed by combining the distance and phase angle characteristics. Moreover, 
by combining these two pieces of information, HRA could be better assessed for short-
term HRV series than existing indices. To test these two hypotheses, we first developed 
an area index (AI) which exactly combined the two characteristics—distance and phase 
angle. We then compared the performance of AI with previously established PI, GI, and 
SI in classifying arrhythmia from normal sinus rhythm, as well as in classifying patients 
with congestive heart failure from healthy control subjects based on long-term (derived 
from >3.6-h ECG recordings) and short-term (500 RR intervals) HRV series, separately. 
In a third analysis, we applied the HRA analyses to short-term heartbeat interval series 
extracted from 5-min ECG of the patients with congestive heart failure and healthy sub-
jects from our clinical trials.
Method
Area index (AI)
AI is defined as the cumulative area of the sectors corresponding to the points that are 
located above the line of identity (LI) divided by the cumulative area of sectors corre-
sponding to all points in the Poincaré plot (except those that are located exactly on LI). 
Specifically, a certain point Pi in the Poincaré plot can be denoted by (RRi,RRi+1) if the 
HRV series is defined as (RR1,RR2, . . . ,RRi,RRi+1, . . . ,RRn). The area of the sector cor-
responding to point Pi, as shown schematically in Fig. 1a, can be calculated by
(1)Si =
1
2
× Rθi × r2
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wherein, r is the radius of the sector; Rθi = θLI − θi; θLI is the phase angle of LI, and θi is 
the phase angle of the i-th point which is defined as θi = atan
(
RRi+1
RRi
)
. Then, AI can be 
calculated by.
wherein, l means the number of points above LI and m means the number of points 
which are not on LI (m = l + b wherein b is the number of points below LI).
Existing indices
Porta’s index (PI)
PI was defined as the number of points below LI divided by the total number of points in 
Poincaré plot except those that are located on LI, specifically,
wherein, b is the number of points below LI and m is the total number of points except 
those that are not on LI.
Guzik’s index (GI)
GI was defined as the distance of points above LI to LI divided by the distance of all 
points in Poincaré plot to LI except those that are located on LI. Specifically,
(2)AI =
∑
l
i=1 |Si|∑
m
i=1 |Si|
× 100
(3)PI = b
m
× 100
(4)GI =
∑
l
i=1 Di∑
m
i=1 Di
× 100
Fig. 1 Schematic representation of heart rate asymmetry algorithms. Blue dots show points in the Poincaré 
plot. Pi is the ith point which can be denoted by (RRi , RRi+1),�RR = RRi+1 − RRi. LI is the line of identity. a Rθi 
is the phase angle of the Pi respect to LI. Filled areas are the sectors we used in AI; b. Di is the distance of Pi to 
LI and θi the phase angle of Pi respect to the abscissa; θLI is the phase angle of LI
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wherein, l means the number of point above LI; m means the number of points in Poin-
caré plot except those which are not on LI; Di is the distance of point Pi to LI which can 
be calculated using 
Slope index (SI)
SI was defined as the phase angle of points above LI divided by the phase angle of all 
points in Poincaré plot except those that are not located on LI. SI can be calculated using
wherein, l means the number of point above LI and m means the number of all points 
except those that are not on LI.
Figure 1b shows schematically the ideas behind PI, GI, and SI.
Materials
Data used in this study were from the PhysioBank archives [25] and a previous clinical 
trial we performed. Specifically, based on PhysioBank database, we proposed to perform 
two case studies: one was between the HRV of healthy subjects (group HEA) and HRV 
of arrhythmia subjects (group ARR); the other one was between the HEA group and 
HRV of patients with congestive heart failure (group CHF).
The HEA group consists of 54 HRV series of healthy subjects (age: 61.4  ±  11.6 
[mean ± SD unless otherwise indicated], 30 men and 24 women) from the normal sinus 
rhythm RR interval database [25]. The original ECG data for them, which are available in 
another database (MIT-BIH normal sinus rhythm database), were digitized at a sampling 
frequency of 128 Hz. RR intervals were calculated based on the incorporated beat anno-
tation files which were obtained by automated analysis with manual review and correc-
tion [25].
For the ARR and CHF groups, the CAST RR interval sub-study database and conges-
tive heart failure RR interval database were used, respectively. The former one contains 
three different sub-sets (corresponding to interventions using three different medica-
tions), among which we only used the Encainide group in order to be comparable with 
a previous study [19]. This sub-set consists of 272 subjects (age: 60.0 ± 10.1, 227 men 
and 45 women) who had an acute myocardial infarction (MI) within preceding 2 years 
and have at least six premature ventricular contractions (PVCs) per hour according to 
24 h Holter ECG (pre-treatment). Those subjects enrolled within 90 days of the index 
MI were required to have left ventricular ejection fractions less than or equal to 55%, 
while those enrolled after this 90-day window were required to have an ejection frac-
tion less than or equal to 40%. The congestive heart failure RR interval database includes 
29 RR intervals from patients with congestive heart failure (age: 55.3  ±  11.6, 8 men 
and 2 women, gender unknown for the rest 19 subjects, New York Heart Association 
[NYHA] class I 4 subjects, II 8 subjects, and III 17 subjects). Similar to the HEA group, 
(5)Di =
|RRi+1 − RRi|√
2
(6)SI =
∑
l
i=1 |Rθi|∑
m
i=1 |Rθi|
× 100
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the original ECG recordings for both the ARR and CHF groups were sampled at 128 Hz 
and the beat annotation files were used to calculate the RR interval [25].
In a third case study, we were still testing the performance on short-term heartbeat 
interval series but this time the actual lengths of the series were different. Instead, they 
were extracted from ECG data of the same length, i.e., 5-min. The data came from one 
of our previous clinical trials [8, 26–29]. 28 CHF patients (age: 59.7 ± 9.8, 16 men and 
12 women) and 29 age- and sex-matched healthy volunteers (age: 59.0 ±  6.9, 15 men 
and 14 women) were recruited and provided informed consents in that study. The HF 
patients were in NYHA class II–III with functional classification confirmed by the ultra-
sonic cardiogram. Measurements were undertaken in a quiet, temperature-controlled 
clinical measurement room (25 ± 3  °C) at Qilu Hospital of Shandong University, by a 
cardiovascular function detection device (CV FD-I) produced by Huiyironggong Tech-
nology Co., Ltd, Jinan, China. ECG data in standard limb II configuration were recorded 
in supine position for 5 min at a sampling frequency of 1 kHz after a 10-min rest. All 
study procedures were approved by the Clinical Ethics Committee of the Qilu Hospital 
of Shandong University and were conducted according to the principles in the Decla-
ration of Helsinki. R peaks were detected through a template matching procedure and 
ectopic R peaks were identified [29]. RR interval series were constructed by the intervals 
of consecutive normal R peaks.
HRA analyses
HRA was assessed by the proposed AI and the three previously established indices. Note 
that before obtaining the Poincaré plots, the raw HRV series were preprocessed by sub-
tracting the corresponding minimum RR interval. In order to understand the perfor-
mance in handling both long-term and short-term HRV series, three analyzing protocols 
on the three databases from PhysioNet were applied: (a) using the complete HRV series 
(corresponding to 3.6–25.95-h ECG recordings, mean ± SD: 22.45 ± 2.08 h); (b) using 
short-term HRV segment (with a length of 500 RR intervals, corresponding to ~5 min 
ECG recordings) randomly selected from the complete series; (c) using 10 subsequent 
short-term HRV segments (500 intervals) with a 50% overlap between each two selected 
from the very beginning of each HRV series. To estimate the HRA of the clinical data, 
the four indices were applied to the short-term heartbeat interval data (obtained from 
5 min ECG recordings) directly.
Statistical analyses
The between-group difference (i.e., HEA vs. ARR, HEA vs. CHF, and healthy volun-
teers vs. CHF) of each specific HRA index was analyzed by the non-parametric Mann–
Whitney U test, with the effect size estimated by Cohen’s d. Classification performance 
was further examined using the area under the receiver-operating characteristic curve 
(ROC). Statistical significance was accepted at p < 0.05. A smaller effect size was consid-
ered if d < 0.5 [30, 31]. All statistical analyses were performed using the SPSS software 
(version 23, IBM, New York, USA).
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Results
HRA assessed using the complete HRV series (analysis protocol a)
HRA results assessed by all four indices (PI, GI, SI, and AI) calculated using the com-
plete HRV series are summarized as mean +  standard error (SE) in Fig.  2. No statis-
tically significant difference was indicated between HEA and ARR groups for both PI 
and GI, whereas both SI and AI suggested that the HRV was more asymmetric in ARR 
group than that in HEA group (p > 0.1 for PI and GI, p < 0.001 for SI and AI), as shown 
in Fig. 2a. Note that any value of HRA that deviates from 50% should suggest asymmet-
ric. Depending on which side (above the LI or below it) weights higher, the value can 
be either smaller or larger than 50%. Besides, larger absolute deviations from 50% sug-
gest stronger asymmetry. However, only SI showed a large effect size (d = 0.9), whereas 
d < 0.3 for the other three indices. For the comparison between HEA and CHF groups, 
PI and GI did not show statistically significant difference (both p > 0.05, d < 0.4) whereas 
SI and AI indicated more asymmetric HRV in CHF group (both p < 0.001; d = 0.8 and 
1.0, respectively for SI and AI), as shown in Fig. 2b.
Figure  3 shows the area under ROC (AUC) ±  SE (standard error) of the four indi-
ces for classifying ARR from HEA groups, as well as classifying CHF group from HEA 
group. Similarly, acceptable AUC values were obtained by SI and AI (ARR vs. HEA: 0.86 
and 0.76, respectively for SI and AI; CHF vs. HEA: 0.75 and 0.78, respectively) while 
AUC < 0.65 for PI and GI in both comparisons. The ROC plots are provided in the Addi-
tional file 1.
HRA assessed using short‑term HRV series (analysis protocols b and c)
HRA results assessed by all four indices calculated based on short-term HRV series (500 
intervals) are summarized in Fig. 4. No statistically significant difference was indicated 
between HEA and ARR groups by PI and GI (both p > 0.8, d < 0.1), whereas SI and AI 
suggested that the HRV was more asymmetric in ARR group than that in HEA group 
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Fig. 2 HRA results estimated by GI, PI, SI, and AI. a A comparison between healthy subjects and subjects with 
arrhythmia (results obtained from 54 healthy subjects and 272 subjects with arrhythmia). b A comparison 
between healthy subjects and CHF patients (results obtained from 54 healthy subjects and 29 CHF patients). 
Bar indicates mean level and error bar the standard error (SE). All HRA indices were calculated based on the 
complete HRV recordings. **p <0.001
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(both p < 0.001; d = 0.5 for SI and 0.7 for AI). For the comparison between HEA and 
CHF groups, PI, GI and SI did not show statistically significant difference (all p > 0.2, 
d  <  0.4) whereas AI indicated more asymmetry of HRV in CHF group (p  <  0.001, 
d = 0.9), as shown in Fig. 4b.
Figure  5 shows the AUC  ±  SE of the four indices for classifying ARR from HEA 
groups, as well as classifying CHF group from HEA group. Again, acceptable AUC val-
ues were only obtained based on AI (AUC =  0.72 and 0.75, respectively, for the two 
comparisons, AUC <0.6 for PI, GI and SI in both comparisons). The ROC plots are pro-
vided in the Additional file 1.
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Fig. 3 AUC results of the four HRA indices. a A comparison between healthy subjects and subjects with 
arrhythmia (results obtained from 54 healthy subjects and 272 subjects with arrhythmia). b A comparison 
between healthy subjects and CHF patients (results obtained from 54 healthy subjects and 29 CHF patients). 
Results were based on the complete HRV recordings and are shown as mean ± stardard error (SE, nonpara-
metric bootstrap-based estimator in SPSS)
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Fig. 4 HRA results estimated by GI, PI, SI, and AI. a A comparison between healthy subjects and subjects with 
arrhythmia (results obtained from 54 healthy subjects and 272 subjects with arrhythmia). b A comparison 
between healthy subjects and CHF patients (results obtained from 54 healthy subjects and 29 CHF patients). 
Bar indicates mean level and error bar the standard error (SE). All HRA indices were calculated based on 500 
intervals of HRV recordings. **p <0.001
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Figures 6 and 7 show the p values, effect sizes and AUC results for each of the four 
HRA indices obtained from the 10 short-term HRV segments (see protocol c). Overall, 
AI showed the best consistency and stability in terms of p value, effect size, and AUC. 
All the other three indices did not suggest statistically significant differences and had 
small effect sizes for both comparisons except SI which indicated significance for dif-
ferentiating ARR from HEA for most cases but only occasionally for differentiating CHF 
from HEA. Besides, the AUC curves for the other three indices were almost all below 
the AUC curves of AI.
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Fig. 5 AUC results of the four HRA indices. a A comparison between healthy subjects and subjects with 
arrhythmia (results obtained from 54 healthy subjects and 272 subjects with arrhythmia). b A comparison 
between healthy subjects and CHF patients (results obtained from 54 healthy subjects and 29 CHF patients). 
Results were based on the 500 intervals of HRV recordings and are shown as mean ± standard error (SE)
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Fig. 6 Performance of the four HRA indices (GI, PI, SI, and AI) in differentiating 272 subjects with arrhythmia 
from 54 healthy subjects. All indices were calculated using 10 different short-term HRV segments. a p values; 
b effect size d; c AUC results (shown the mean and error bar the standard error SE)
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HRA results of the clinical short‑term heartbeat interval data
Figure 8a summarizes the HRA results of the heartbeat interval series (extracted from 
5-min ECG) from our clinical studies. No statistically significant difference in PI, GI and 
SI (all p > 0.1, and d < 0.5) was observed between CHF patients and healthy volenteers. 
However, AI suggested statistically significantly increased asymmetry in CHF patients 
compared to healthy volunteers (p < 0.001, d = 1.0). Figure 8b shows the AUC ± SE of 
the four indices for classifying CHF patients from HEA groups. Only AI indicated rela-
tively larger AUC results (0.77) while AUC <0.7 for all the other three indices. The ROC 
plots are provided in the Additional file 1.
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Fig. 7 Performance of the four HRA indices (GI, PI, SI, and AI) in differentiating 29 CHF patients from 54 
healthy subjects. All indices were calculated using 10 different short-term HRV segments. a p values; b effect 
size d; c AUC results (shown the mean and error bar the standard error SE)
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Fig. 8 Comparison of HRA estimated by GI, PI, SI, and AI, between 28 CHF patients and 29 healthy volunteers 
for the clinical data. All HRA indices were calculated based on 5 min ECG recordings. a Bar indicates mean of a 
specific HRA index and error bar standard error (SE). **p < 0.001. b AUC results are shown as mean ± stardard 
error (SE)
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Discussion
The heart does not always beat at the same speed. Instead, it accelerates or decelerates 
over time due to mostly the regulation of autonomic nervous system (ANS) [5, 9, 11, 12, 
14, 32–35]. The ANS consists of two branches—sympathetic nervous system, the acti-
vation of which speeds up the heartbeat, and parasympathetic nervous system which, 
when activated, slows down the heartbeat [3, 9, 12, 13, 22, 32, 34, 36]. There is an intrin-
sic balance between the sympathetic and parasympathetic tones [32]. But this balance 
does not mean that these two branches contribute equally to heartbeat; instead, the bal-
ance may shift to either branch in different conditions and the shift changes from time to 
time [36, 37] which, consequently, gives rise to an asymmetry between the acceleration 
and deceleration of heart rate.
We proposed in this study a novel method—area index (AI)—for measuring the heart 
rate asymmetry (HRA). AI combined information from two aspects (distance and phase 
angle of each accelerated or decelerated heartbeat to the previous beat), since the change 
in one of them may not necessarily introduce a change in another, as we shown based 
on the simulation data (see Additional file 1). Thus, the established HRA measures that 
were defined based on one feature were not robust like AI (i.e., PI only counted on the 
number of accelerated or decelerated heartbeats, GI considered only the distance, and SI 
only took phase angle into account). A shortened data recording may further deteriorate 
this limitation. Our results from the three different case studies support our hypotheses, 
showing that AI is a more robust measure of HRA and it performs better than existing 
indices for assessing HRA from short-term HRV signals. Using the complete recordings, 
the performance of AI was comparable to SI whereas both PI and GI failed in classi-
fying arrhythmia from normal sinus rhythm as well as in differentiating patients with 
congestive heart failure to healthy control subjects (Figs. 2, 3). On the other hand, only 
AI showed acceptable AUC values whereas all the other three methods failed when cut-
ting the completing recording down to short-term series (Figs. 4, 5). The performance of 
AI was also quite robust when we applied different short-term segments (Figs. 6, 7). In 
addition, results from our clinical data further supported the findings that for short-term 
series AI performed better than existing indices (Fig. 8). In this specific case study, the 
lengths of the heartbeat interval series were not constant; instead, we fixed the lengths 
of the ECG recordings to 5 min as this is the typical setting in most of the commercial-
ized devices that have built-in short-term HRV analysis module. Even though the actual 
lengths of the series varied, we expected that AI could still perform better. Our observa-
tions seem to support our expectation. In order to better understand how the results 
change in this different setting, we repeated the analysis protocol c) by using the length 
of ECG (5-min) as the window length. Still, a 50% overlap between each two windows 
were set. All the results (Fig. 9) held which indicates quite consistent performance of the 
proposed AI.
Overall, the results suggest that the distance could be quite sensitive and the informa-
tion related to asymmetry hidden in distance can be confounded by long-term record-
ings. That could explain the fact that GI did not show acceptable AUC values for both 
cases when using long-term recordings and the ROC for GI (which used only the dis-
tance information) changed dramatically when using short-term recordings (Figs.  3, 
5). However, though it changed, the AUC values were still not acceptable which might 
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suggest that the distance information should be sensitive to mostly the deceleration part 
which corresponds to the parasympathetic tone [3, 9, 12, 32]. On the other hand, the 
phase angle might be related more to the acceleration part which corresponds to the 
sympathetic tone [3, 9, 12, 32], so that it required long data to distinguish healthy from 
pathology. That is probably why SI worked well when using long-term recordings but 
failed in short-term analysis. Intriguingly, there seems to be some interaction between 
the phase angle and distance so that when they were combined (as was done for our 
prosed AI), the asymmetry was able to be characterized using both the long- and short-
term recordings.
In addition, the calculation of phase angle requires a “reference point”—the original 
point in Poincaré plot. In our study, we have had the minimum RR interval subtracted 
from each RR interval (see “HRA analyses”) so that the original point has been shifted 
accordingly. Otherwise, there will be a large “null” area in the Poincaré plot which may 
decrease the sensitivity of phase angle. There are also other ways to adjust this reference. 
We are planning to investigate systematically the influence of reference point in the cal-
culation of SI and AI in future studies.
From a clinical point of view, we note that even though the proposed AI shows bet-
ter suitability to short-term applications and increased robustness compared to existing 
methods, the AUC values were still relatively low which means the power of AI for the 
diagnosis of the studied disease is still quite poor. However, as the measurement itself 
is noninvasive and costless, instead of acting as a diagnostic tool that can find its use in 
clinical, the AI would have high potential to be a metric for monitoring the ANS balance, 
which in turn may help evaluate the cardiovascular risk for healthy individuals. Plenty of 
previous studies have evidenced that the autonomic imbalance can attribute greatly to 
morbidity and mortality in cardiovascular diseases and have improved predictive power 
for cardiovascular events than traditional risk factors [35, 38–41]. Our study which 
aimed at short-term HRV analysis provides the opportunity to incorporate the real-time 
HRA monitoring to some modern wearable devices, e.g. wrist watch or cell phone with 
built-in ECG/heart rate measurement module, which will become rather commonplace 
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and will surely be of significant help not only now but also in the future era. Neverthe-
less, further clinical studies are yet warranted to verify whether our proposed measure is 
clinically useful for identifying individuals at risk for cardiovascular diseases or as a tool 
for evaluating different therapeutic interventions.
Conclusion
A novel area index (AI) for assessing the heart rate asymmetry (HRA) was developed in 
this study. AI combines the distance and phase angle information of points in the Poin-
caré plot. Analyses using both the publically available databases and the clinical data-
base suggested better performance of AI in term of classification ability and robustness, 
which are more obvious when the available heartbeat interval series were short (i.e., 500 
intervals or 5  min ECG). AI may potentially offer the opportunity to provide prompt 
feedback on the change of HRA and even monitor the longtime HRA profile which may 
be helpful for identifying people of high cardiovascular risk in ambulatory cardiovascu-
lar monitoring.
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